Under the leadership of Gabriela Kramer-Marek, we are seeking to appoint a Postdoctoral Research Fellow to join her group in order to manage studies relating to targeted radionuclide therapy (TRT) in both in vitro and in vivo models of glioblastoma.
Key Requirements
1. The successful candidate must have a PhD in chemical or biomedical science (or relevant field).
2. Advanced knowledge in radiolabelling of monoclonal antibodies and small proteins
3. Expertise in development and optimisation of in vitro and in vivo efficacy assays.
4. Advanced knowledge of preclinical molecular imaging.
5. Knowledge of glioblastoma biology.
6. Experience in cell biology techniques(e.g. confocal microscopy, FACS analysis, Western blotting, IHC), Good verbal and written communication skills, including good presentation skills.
7. Excellent inter-personal skills with an ability to work co-operatively in a multidisciplinary setting, working closely with biologists, chemists and radiochemists.
8. Possess excellent written and verbal communication skills and maintain accurate and up-to-date records of all findings
Department/Directorate Information
The Division of Radiotherapy and Imagingis investigating new imaging methods to diagnose cancer, and ways in which advances in technology and molecular biology can improve radiation treatment. It is also increasingly concerned with the use of imaging to evaluate the response to treatment in vivo, through techniques measuring aspects of tumour biology. Preclinical Molecular Imaging Group focuses on development of innovative preclinical imaging biomarkers for non-invasive and real-time mapping of specific proteins involved either in early tumour cell response or de novo resistance to new treatment combinations, with an emphasis on targeted cancer therapies and immunotherapies.